CELEX: 62017CB0327
Language: en
Date: 2018-04-12 00:00:00
Title: Case C-327/17 P: Order of the Court (Seventh Chamber) of 12 April 2018 — Cryo-Save AG v European Union Intellectual Property Office (EUIPO), MedSkin Solutions Dr. Suwelack AG (Appeal — European Union trade mark — Revocation proceedings — Withdrawal of the application for revocation — Appeal which has become devoid of purpose — No need to adjudicate)

201806220151970742018/C 240/103272017CJC24020180709EN01ENINFO_JUDICIAL201804127822Case C-327/17 P: Order of the Court (Seventh Chamber) of 12 April 2018 — Cryo-Save AG v European Union Intellectual Property Office (EUIPO), MedSkin Solutions Dr. Suwelack AG (Appeal — European Union trade mark — Revocation proceedings — Withdrawal of the application for revocation — Appeal which has become devoid of purpose — No need to adjudicate)
 ---documentbreak--- C2402018EN720120180412EN00107282Order of the Court (Seventh Chamber) of 12 April 2018 — Cryo-Save AG v European Union Intellectual Property Office (EUIPO), MedSkin Solutions Dr. Suwelack AG
   (Case C-327/17 P) (
         1
      )
   ‛(Appeal — European Union trade mark — Revocation proceedings — Withdrawal of the application for revocation — Appeal which has become devoid of purpose — No need to adjudicate)’2018/C 240/10Language of the case: German
      Parties
   
   
      Appellant: Cryo-Save AG (represented by: C. Onken, Rechtsanwältin)
   
      Other parties to the proceedings: European Union Intellectual Property Office (EUIPO) (represented by: D. Hanf, Agent), MedSkin Solutions Dr. Suwelack AG (represented by: A. Thünken, Rechtsanwalt)
   
      Operative part of the order
   
   
            1.
         
         
            There is no need to adjudicate on the present appeal.
         
      
            2.
         
         
            Cryo-Save AG shall pay the costs incurred by the European Union Intellectual Property Office (EUIPO) in the present proceedings.
         
      
            3.
         
         
            Cryo-Save AG and MedSkin Solutions Dr. Suwelack AG shall bear their own costs.
         
      (
         1
      )	OJ C 330, 2.10.2017.